[Operable colon cancer: initial strategy].

Thierry André1, Noshine Tuvignon, Julien Taieb

  • 1Service d'hépato-gastro-entérologie, Groupe hospitalier La Pitié-Salpêtrière, AP-HP, 75651 Paris Cedex 13. thierry.andre@psl.aphp.fr

La Revue Du Praticien
|January 5, 2011
PubMed
Summary

Screening and optimized surgery have improved colon cancer survival rates. Adjuvant therapy with oxaliplatin and fluoropyrimidine benefits stage-III patients, reducing recurrence.